JP6750941B2 - 精神障害の治療 - Google Patents
精神障害の治療 Download PDFInfo
- Publication number
- JP6750941B2 JP6750941B2 JP2015535741A JP2015535741A JP6750941B2 JP 6750941 B2 JP6750941 B2 JP 6750941B2 JP 2015535741 A JP2015535741 A JP 2015535741A JP 2015535741 A JP2015535741 A JP 2015535741A JP 6750941 B2 JP6750941 B2 JP 6750941B2
- Authority
- JP
- Japan
- Prior art keywords
- human
- mab
- subject
- mabp1
- anxiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261709741P | 2012-10-04 | 2012-10-04 | |
| US61/709,741 | 2012-10-04 | ||
| PCT/US2013/062899 WO2014055541A1 (en) | 2012-10-04 | 2013-10-01 | Treatment of psychiatric conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020090717A Division JP2020143133A (ja) | 2012-10-04 | 2020-05-25 | 精神障害の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015531396A JP2015531396A (ja) | 2015-11-02 |
| JP2015531396A5 JP2015531396A5 (enrdf_load_stackoverflow) | 2016-11-17 |
| JP6750941B2 true JP6750941B2 (ja) | 2020-09-02 |
Family
ID=50435375
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015535741A Active JP6750941B2 (ja) | 2012-10-04 | 2013-10-01 | 精神障害の治療 |
| JP2020090717A Pending JP2020143133A (ja) | 2012-10-04 | 2020-05-25 | 精神障害の治療 |
| JP2022144756A Withdrawn JP2022177132A (ja) | 2012-10-04 | 2022-09-12 | 精神障害の治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020090717A Pending JP2020143133A (ja) | 2012-10-04 | 2020-05-25 | 精神障害の治療 |
| JP2022144756A Withdrawn JP2022177132A (ja) | 2012-10-04 | 2022-09-12 | 精神障害の治療 |
Country Status (7)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2582391T (pt) | 2010-06-18 | 2019-01-11 | Xbiotech Inc | Tratamento da artrite |
| KR102314003B1 (ko) | 2010-08-23 | 2021-10-19 | 얀센 바이오테크 인코포레이티드 | 종양성 질병들에 대한 치료 |
| US9724409B2 (en) | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
| CN103906536A (zh) | 2011-09-23 | 2014-07-02 | 埃克斯生物科技公司 | 恶病质治疗 |
| US9545441B2 (en) | 2012-09-18 | 2017-01-17 | Xbiotech, Inc. | Treatment of diabetes |
| WO2018150265A1 (en) * | 2017-02-16 | 2018-08-23 | Xbiotech, Inc. | Treatment of hidradenitis suppurativa |
| CN120113325A (zh) | 2022-11-04 | 2025-06-06 | 松下电器（美国）知识产权公司 | 终端、基站、通信方法及集成电路 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5959085A (en) * | 1993-11-23 | 1999-09-28 | Schering Corporation | Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| GB9405021D0 (en) * | 1994-03-15 | 1994-04-27 | Unilever Plc | Skin treatment composition |
| US5455234A (en) * | 1994-03-16 | 1995-10-03 | Ahluwalia; Gurpreet S. | Inhibition of hair growth |
| JP2002226457A (ja) * | 2001-02-02 | 2002-08-14 | Ajinomoto Co Inc | 新規シスチン誘導体及び炎症因子活性化抑制剤 |
| EP2285409B1 (en) * | 2008-05-30 | 2016-04-20 | XBiotech, Inc | Il-1 alpha antibodies |
| JP2012516153A (ja) * | 2009-01-29 | 2012-07-19 | アボット・ラボラトリーズ | Ｉｌ−１結合タンパク質 |
| JP6062918B2 (ja) * | 2011-04-01 | 2017-01-18 | エックスバイオテク, インコーポレイテッドXbiotech, Inc. | 皮膚科的病理の治療 |
| US9724409B2 (en) * | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
-
2013
- 2013-10-01 EP EP13843079.8A patent/EP2903643A4/en not_active Withdrawn
- 2013-10-01 AU AU2013327498A patent/AU2013327498B2/en not_active Ceased
- 2013-10-01 CN CN201380050428.0A patent/CN104684581A/zh active Pending
- 2013-10-01 WO PCT/US2013/062899 patent/WO2014055541A1/en active Application Filing
- 2013-10-01 KR KR1020157009988A patent/KR20150064091A/ko not_active Ceased
- 2013-10-01 CA CA2886757A patent/CA2886757C/en active Active
- 2013-10-01 JP JP2015535741A patent/JP6750941B2/ja active Active
-
2020
- 2020-05-25 JP JP2020090717A patent/JP2020143133A/ja active Pending
-
2022
- 2022-09-12 JP JP2022144756A patent/JP2022177132A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2886757A1 (en) | 2014-04-10 |
| EP2903643A1 (en) | 2015-08-12 |
| JP2020143133A (ja) | 2020-09-10 |
| AU2013327498B2 (en) | 2018-06-28 |
| EP2903643A4 (en) | 2016-06-15 |
| JP2022177132A (ja) | 2022-11-30 |
| CA2886757C (en) | 2022-04-05 |
| JP2015531396A (ja) | 2015-11-02 |
| CN104684581A (zh) | 2015-06-03 |
| KR20150064091A (ko) | 2015-06-10 |
| AU2013327498A1 (en) | 2015-04-02 |
| WO2014055541A1 (en) | 2014-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11191831B2 (en) | Treatment of psychiatric conditions | |
| JP6453278B2 (ja) | 皮膚科的病理の治療 | |
| JP6750941B2 (ja) | 精神障害の治療 | |
| US12116405B2 (en) | Arthritis treatment | |
| KR102104296B1 (ko) | 종양성 질병들에 대한 치료 | |
| HK40013773A (zh) | 皮肤病学病状的治疗 | |
| HK1187260A (en) | Treatment for dermatological pathologies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160927 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160927 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170718 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180327 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180626 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20181127 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200525 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200813 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6750941 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |